Colgate-Palmolive 10-Qquarter ended 2026-06-30

Executive Summary

Colgate-Palmolive delivered better gross margins and cash generation in Q2 2026, but reported sales growth of 4.9% overstated underlying momentum: organic growth was 2.4%, with currency contributing materially. Productivity savings supported profitability before restructuring charges, while higher advertising, overhead and program expenses pushed GAAP earnings lower. Latin America and Asia Pacific offset North American weakness, but declining Hill’s volumes show that premium pet nutrition is not immune to softer demand. The investment thesis rests on converting productivity savings and brand spending into sustained organic growth—not relying on currency benefits or adjusted earnings alone.

Key Financial Highlights

• Cash conversion: H1 OCF of $1.74B, +17% Y/Y, exceeded net income attributable to Colgate-Palmolive of $1.34B; capex of $266M produced FCF of $1.48B. Restructuring charges of $305M exceeded program cash payments of $64M, illustrating why reported expense and cash outflow diverged.
• Capital return: H1 dividends of $879M and treasury-share purchases of $597M together consumed all FCF. H1 basic weighted-average shares fell 1.3% Y/Y to 801M; period-end shares outstanding were 797M. Stock-based compensation rose 42% to $78M.
• Spending pressure: Q2 advertising increased 15% to $777M, or 14.5% of sales; greater brand investment and overhead absorbed part of the gross-margin improvement.
• Currency effects: H1 currency-contract losses in selling, general and administrative expenses were $73M vs gains of $129M, a $202M adverse swing despite favorable sales translation.

Business Developments

• Productivity expansion: Management expanded its Strategic Growth and Productivity Program in 4/2026 to realign the organization, optimize supply chains and reduce overhead. Expected cumulative pre-tax charges are $350M–$550M, with annualized pre-tax savings of $200M–$300M after implementation and substantially all charges expected by 12/31/2028.
• Geographic divergence: Q2 organic growth reached 5.3% in Latin America and 5.2% in Asia Pacific, versus −3.0% in North America, where U.S. toothpaste and personal-care weakness weighed on sales. Global toothpaste share nevertheless rose 0.2 percentage point to 41.3% YTD, suggesting local weakness rather than broad franchise erosion.
• Portfolio development: Oral Care supplied 44% of sales and Pet Nutrition 22%. The $301M Prime100 acquisition added Australian fresh pet food; however, Hill’s Q2 volume declined 1.2% despite an acquisition contribution, with lower private-label sales weighing on performance.

Risk Assessment

• Demand and competition: Management expects category softness through H2 2026; consumer trade-down, private-label competition and retailer bargaining power threaten volume and pricing.
• Execution and cost pressure: The productivity program requires 80%–90% of charges in cash, while raw-material inflation reduced Q2 gross-margin improvement by 220 bp, making delivery of savings consequential.
• Currency exposure: Approximately two-thirds of sales originate outside the U.S.; favorable translation boosted Q2 growth by 2.4 percentage points, while hedge losses demonstrate that currency benefits do not flow uniformly into earnings.
• Financing dependence: Commercial paper increased to $1.15B from $147M at year-end, and $1.35B of cash was held by foreign subsidiaries; continued shareholder distributions increase reliance on available funding.
• Legal and tax exposure: Reasonably possible litigation losses above accruals reach ≈$225M, alongside a disputed IRS assessment of ≈$168M; adverse outcomes could materially affect an individual period.

A 10-Q does not have to restate the risk factors in the annual report. Full list: the company's 10-Ks on SEC.

Strategic Outlook and Investor Actionables

Management is betting that productivity savings and increased advertising will defend its global brands while funding growth, with fresh pet food extending Hill’s opportunity. The key threat is that weak demand absorbs those investments before savings become durable earnings and cash.

• Brand recovery: Starting from North American organic growth of −3.0% and global toothpaste share of 41.3%, later filings should show regional recovery without share erosion; continued contraction would weaken the investment case.
• Hill’s demand: Starting from 2.1% organic growth and −1.2% volume, success means volume recovery alongside growth; persistent volume declines would signal dependence on pricing and currency.
• Productivity delivery: Against $318M of cumulative charges, test management’s $200M–$300M annualized savings objective; improving GAAP operating profit would support execution, while recurring charges without improvement would undermine it.
• Cash discipline: H1 FCF exactly covered dividends and repurchases; sustained coverage with stable or falling total debt would validate capital returns, while rising borrowing would indicate distributions exceeding internally generated cash.